KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $197 | -18.3% | 9,545 | -15.5% | 0.00% | 0.0% |
Q1 2024 | $241 | +48.8% | 11,295 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $162 | -21.4% | 11,295 | -50.0% | 0.00% | 0.0% |
Q3 2023 | $206 | +71.7% | 22,590 | +100.0% | 0.00% | 0.0% |
Q2 2023 | $120 | -13.0% | 11,295 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $138 | -1.4% | 11,295 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $140 | -99.9% | 11,295 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $154,000 | -25.6% | 11,295 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $207,000 | +13.7% | 11,295 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $182,000 | +15.2% | 11,295 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $158,000 | -25.5% | 11,295 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $212,000 | -10.2% | 11,295 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $236,000 | -26.0% | 11,295 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $319,000 | -13.6% | 11,295 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $369,000 | – | 11,295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |